Dr. Billings is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
909 Fulton Ave. SE
M Health Fairview CSC
Minneapolis, MN 55455Phone+1 612-273-8383- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
- University of MinnesotaResidency, Internal Medicine, 1992 - 1995
- Rush Medical College of Rush University Medical CenterClass of 1992
Certifications & Licensure
- MN State Medical License 1994 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Mar 01
- A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Start of enrollment: 2006 Feb 01
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.Rebecca Freese, Nicholas Marka, Kathleen Mahan, Sarah Kiel, Jordan Dunitz, Joanne Billings> ;Heliyon. 2024 Mar 30
- 1 citationsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.David Nichols, Alex Gifford, Renee Russell, Katherine Odem-Davis, Julia Young, Rodolfo Amaro-Galvez, Joanne Billings, Zubin Mukadam, Nicole Mayer-Hamblett> ;Annals of the American Thoracic Society. 2024 Feb 1
- 10 citationsSafety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.Ahmet Z Uluer, Gordon MacGregor, Pilar Azevedo, Veronica Indihar, Claire Keating, Marcus A Mall, Edward F McKone, Bonnie W Ramsey, Steven M Rowe, Ronald C Rubenstein, ...> ;The Lancet. Respiratory Medicine. 2023 Jun 1
- Join now to see all
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
Grant Support
- Multidose Safety And Tolerability Study Of Liposomal Amikacin For Inhalation (ArNational Center For Research Resources2009
- Kb001-03: A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-DoseNational Center For Research Resources2009
- Expanded Access Program For Aztreonamn Lysine For Inhalation In Patients With CYNational Center For Research Resources2009
- Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2008
- A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2008
- Women'S Health In Cystic FibrosisNational Center For Research Resources2004–2007
- A Phase II, Randomized, Double Blind, Parallel Dose Study Of Oral Theraclec-TotaNational Center For Research Resources2005–2006
- Women'S Health In Cystic FibrosisNational Heart, Lung, And Blood Institute2001–2005
Hospital Affiliations
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: